Proxy Votes Now

Home › Funds › BNY Mellon › BNY Mellon Small/Mid Cap Growth Fund

BNY Mellon Small/Mid Cap Growth Fund (DBMAX) proxy voting record 2025-2026

Fund family: BNY Mellon · Filed by BNY Mellon Investment Funds I (CIK 799295) · SEC series S000011499

Share classes and tickers: DBMAX (C000075527), DBMCX (C000075528), DBMYX (C000130460), DBMZX (C000193013), SDSCX (C000031760)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 542 with, 6 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 4 FOR, 3 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with BNY Mellon as a whole

The same two figures as BNY Mellon’s manager page (141,760 ballot items across 60 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBNY MellonItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)90.9%51993.1%117,600
Backed environmental and social shareholder proposals at US companiesn/a11.8%1,473

Where this fund voted differently from most BNY Mellon funds

Each ballot item this fund voted is set against the votes of the other BNY Mellon funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most BNY Mellon funds on 12 items (2.5% of the 488 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost BNY Mellon fundsMgmtResult
Cytokinetics, Incorporated2026-05-27To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.AgainstFOR — 6 of 8 BNY Mellon fundsAgainstApproved, 97.2% support
Patrick Industries, Inc.2026-05-14To approve, in an advisory and non-binding vote, the compensation of the Company's named executive officers for fiscal year 2025.AgainstFOR — 6 of 8 BNY Mellon fundsAgainstPassed (calculated), 97.3% support
Pool Corporation2026-04-29Ratification of the retention of Ernst & Young LLP, certified public accountants, as our independent registered public accounting firm for the 2026 fiscal year.AgainstFOR — 4 of 5 BNY Mellon fundsAgainstApproved, 96.5% support
SiTime Corporation2026-05-29To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.AgainstFOR — 5 of 7 BNY Mellon fundsAgainstApproved, 82.1% support
Bio-Techne Corporation2025-10-30Approve, on an advisory basis, the compensation of our executive officers.AgainstFOR — 6 of 10 BNY Mellon fundsAgainstApproved, 72.1% support
The Timken Company2026-05-08Approval, on an advisory basis, of our named executive officer compensation.ForAGAINST — 5 of 8 BNY Mellon fundsForApproved, 74.6% support
Bio-Techne Corporation2025-10-30Elections of Directors: Alpna SethAgainstFOR — 4 of 6 BNY Mellon fundsAgainstElected, 95.8% support
MKS Inc.2026-05-11The approval, on an advisory basis, of executive compensation.AgainstFOR — 5 of 9 BNY Mellon fundsAgainst—
Onto Innovation Inc.2026-05-20To approve, on an advisory (non-binding) basis, the compensation of our named executive officers as disclosed in the proxy statement; andAgainstFOR — 5 of 9 BNY Mellon fundsAgainstApproved, 97.1% support
GeneDx Holdings Corp.2026-06-18Approval, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 4 of 7 BNY Mellon fundsAgainstPassed (calculated), 93.9% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. ForbesWithholdFOR — 3 of 5 BNY Mellon fundsAgainstElected, 92.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. CerulliWithholdFOR — 3 of 5 BNY Mellon fundsAgainstElected, 83.6% support

Download all 12 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.8% of this fund’s 548 such votes could be given a sector; the other 23 (4.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Industrials16953.0%
Health Care13800.0%
Consumer Discretionary11010.9%
Technology6100.0%
Energy2700.0%
Finance1300.0%
Basic Materials700.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3540
Audit-related660
Say-on-Pay640
Compensation250
Corporate Governance244
Capital Structure130
Extraordinary Transactions61
Shareholder Rights and Defenses40
Environment or Climate11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Casey's General Stores, Inc.September 3, 2025$43M151
Repligen CorporationMay 14, 2026$36M110
Guardant Health, Inc.June 17, 2026$29M50
Bio-Techne CorporationOctober 30, 2025$28M120
SiTime CorporationMay 29, 2026$23M50
Flowserve CorporationMay 14, 2026$22M121
Roper Technologies, Inc.May 19, 2026$21M141
Herc Holdings Inc.May 14, 2026$20M100

Notable votes against management

MeetingCompanyProposalFundMgmt
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
May 14, 2026Flowserve CorporationShareholder Proposal requesting an annual advisory shareholder vote regarding Flowserve stock repurchases. Shareholder proposalAgainstFor
May 19, 2026Roper Technologies, Inc.Shareholder proposal regarding a strategic review of a proposed spin-off of the Application Software and Network Software segments. Shareholder proposalAgainstFor
May 8, 2026The Timken CompanyConsideration of a shareholder proposal asking our Board of Directors to take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. Shareholder proposalForAgainst
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalForAgainst
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalForAgainst

Search this fund’s votes by company

557 ballot items at 66 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, BNY Mellon Small/Mid Cap Growth Fund (DBMAX) voted at 66 shareholder meetings of 65 companies, on 557 ballot items in all. Where management made a recommendation, the fund followed it on 98.9% of the items and voted against it 6 times. Its most frequent area of disagreement was corporate governance (4 of its votes against management). It voted on 7 shareholder proposals. It voted FOR the board's own proposals less often than BNY Mellon's funds as a whole (90.9% against 93.1%). It voted differently from most BNY Mellon funds on 12 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BNY Mellon’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.